Skip to main content
. 2022 May 24;13:863826. doi: 10.3389/fneur.2022.863826

Table 6.

Adverse effects reported during the KD treatment.

Adverse effect n (%)
No adverse effect 30 (56.6)
Gastrointestinal disturbance 20 (37.7)
Hyperlipidemia 6 (11.3)
Infectious disease 3 (5.7)
Kidney stones 2 (3.8)
Slow growth 2 (3.8)
Hypoproteinemia 1 (1.9)
Hyperuricemia 1 (1.9)